Skip to content
naulon

Not checkedNot checked for notices yet.

AKT1 and AKT2 Promote Malignant Transformation in Human Brain Glioma LN229 Cells

Jian Zou, Kun Wang, Lei Han and 4 more

Cancer Biology & Medicine · 2011

doi:10.1007/s11805-011-0573-9 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

OBJECTIVE To confirm the role played by AKT1 and AKT2 in the b-catenin/Tcf-4 signaling pathway in promoting malignant transfor-mation of glioma cells.METHODS LN229 cells were divided into five groups: a control group, acetone (ACE)group, acetylsalicylic acid (ASA; aspirin) group, ASA+AKT1 plasmid group and ASA+AKT2 plasmid group. Western blot and PCR were used to detect the expression of AKT1 and AKT2 after dealing with ASA and transferring AKT1/2 genes into LN229 cells. Cell proliferation was determined by flow cytometry, cell invasion was evaluated by transwell assay and cell apoptosis was detected with annexin V staining. The molecules regulating proliferation and invasion were examined by western blot analysis.RESULTS Aspirin down-regulates AKT1 and AKT2 expression by modulating b-catenin/Tcf-4 activity. AKT1 and AKT2 can enhance cell proliferation and invasion by up-regulating the expression of cyclin-D and matrix metalloprotein-9 (MMP-9) in LN229 glioma cells.CONCLUSION AKT1 and AKT2 play an important role in the b- catenin/Tcf-4 signaling pathway promoting malignant transformation; AKT1 is more effective than AKT2. AKT1 and AKT2 may be potential targets for brain glioma therapy and an effective way to prevent metastasis of gliomas.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.